Wenkang Gao

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

From metabolic dysregulation to clinical alert: a novel panel of biomarkers for staging alcohol-associated liver disease.

From metabolic dysregulation to clinical alert: a novel panel of biomarkers for staging alcohol-associated liver disease.

Journal: Journal of translational medicine

Published: November 10, 2025

Escherichia coli expressing the kpsM gene exacerbates drug-induced liver injury through up-regulating α1,2-fucosyltransferase and disturbing the host taurine metabolism-from animal models and clinical studies.

Escherichia coli expressing the kpsM gene exacerbates drug-induced liver injury through up-regulating α1,2-fucosyltransferase and disturbing the host taurine metabolism-from animal models and clinical studies.

Journal: Journal of advanced research

Published: July 11, 2025

Intestinal Fut2 deficiency exacerbated alcohol-related liver disease by disrupting nicotinamide metabolism.

Intestinal Fut2 deficiency exacerbated alcohol-related liver disease by disrupting nicotinamide metabolism.

Journal: Clinical and translational medicine

Published: May 16, 2025

Harnessing the power of the gut microbiome: a review of supplementation diagnosis and therapy for liver cirrhosis.

Harnessing the power of the gut microbiome: a review of supplementation diagnosis and therapy for liver cirrhosis.

Journal: Cellular and molecular life sciences : CMLS

Published: April 25, 2025

Ferroptosis and gut microbiota: A new horizon in alcohol-associated liver disease management.

Ferroptosis and gut microbiota: A new horizon in alcohol-associated liver disease management.

Journal: Cellular and molecular life sciences : CMLS

Published: January 22, 2025

Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease.

Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease.

Journal: Biomedicines

Published: December 07, 2024

Gram-positive probiotics improves acetaminophen-induced hepatotoxicity by inhibiting leucine and Hippo-YAP pathway.

Gram-positive probiotics improves acetaminophen-induced hepatotoxicity by inhibiting leucine and Hippo-YAP pathway.

Journal: Cell & bioscience

Published: November 02, 2024

Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study.

Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study.

Journal: Journal of clinical and translational hepatology

Published: July 15, 2024

Suppression of intestinal Ticam1 ameliorated MASH via Akkermansia muciniphila QAA37749.1 mediated betaine transformation.

Suppression of intestinal Ticam1 ameliorated MASH via Akkermansia muciniphila QAA37749.1 mediated betaine transformation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: April 23, 2024

A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD.

A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD.

Journal: Atherosclerosis

Published: December 30, 2023

Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.

Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.

Journal: Toxins

Published: July 14, 2022

Gut non-bacterial microbiota contributing to alcohol-associated liver disease.

Gut non-bacterial microbiota contributing to alcohol-associated liver disease.

Journal: Gut microbes

Published: October 29, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026